トランスフェクション試薬・装置市場レポート：動向、予測、競合分析 (2031年まで)

世界のトランスフェクション試薬・装置市場の将来性は、学術・研究機関および製薬・バイオテクノロジー企業市場での機会により有望視されています。トランスフェクション試薬・装置の世界市場は、2025年から2031年までのCAGRが6.5%で、2031年までに推定21億米ドルに達すると予想されています。この市場の主な促進要因は、世界中で慢性疾患の負担が増加していること、合成遺伝子の需要が高いこと、トランスフェクションの技術進歩です。

• Lucintel社の予測によると、製品別では、主要企業が試薬ポートフォリオを拡充するために多くの製品を発売しているため、試薬は予測期間中に高い成長が見込まれます。
• 最終用途別では、世界の疾病負担の増加や試薬・機器の採用増加により、製薬・バイオテクノロジー企業が最大セグメントであり続けると思われます。
• 地域別では、ゲノム研究開発への投資増加、タンパク質治療薬への需要拡大、同地域の大手企業の存在により、北米が予測期間中最大セグメントであり続けると思われます。

トランスフェクション試薬・装置市場の戦略的成長機会

トランスフェクション試薬・装置市場には、いくつかの戦略的成長機会が存在します：

• 遺伝子治療：遺伝子治療におけるトランスフェクション技術の利用拡大により、治療用遺伝子の送達が強化され、治療成績が向上するため、大きな成長機会がもたらされます。
• 創薬：遺伝子機能および薬物相互作用の迅速な研究が可能になるため、新薬開発が加速されます。
• がん研究：遺伝子導入手法の強化はがん研究にとって不可欠であり、がん関連遺伝子や治療標的の研究を向上させる。
• 再生医療：トランスフェクション技術は、再生医療における新しい治療法の開発に不可欠であり、組織工学や幹細胞研究の進歩に貢献しています。
• 農業バイオテクノロジー：農業バイオテクノロジーにおけるトランスフェクション技術の可能性は大きく、食品の安全性と農業生産性の向上を目的とした遺伝子組み換え作物の開発に役立っています。

こうした成長機会により、トランスフェクション技術の応用がさまざまな分野で拡大し、市場の成長と技術革新が促進されています。

トランスフェクション試薬・装置市場の促進要因・課題

トランスフェクション試薬・装置市場に影響を与えるさまざまな要因には、技術、経済、規制などがあります。以下は主な促進要因と課題の分析です：

トランスフェクション試薬・装置市場の促進要因には、以下のようなものがあります：

• 技術進歩：ナノ粒子や自動化などの技術革新は遺伝子導入を改善し、効率と効果の向上を通じて市場成長を促進します。
• 研究投資の増加：バイオテクノロジーやゲノム研究への投資の増加は、高度なトランスフェクション技術への需要を押し上げ、市場拡大につながります。
• 遺伝子治療に対する需要の高まり：遺伝子治療の応用拡大により、効果的なトランスフェクション技術へのニーズが高まっており、市場成長の促進要因となっています。
• 個別化医療：個別化医療の進展により、個々の患者に合わせたトランスフェクション技術が必要となり、カスタマイズされたソリューションに対する需要がさらに高まっています。

トランスフェクション試薬・装置市場における課題は以下のとおりです：

• 高コスト：特に発展途上地域の小規模研究施設では、高度なトランスフェクション試薬・装置のコストが使用を妨げる可能性があります。
• 技術の複雑さ：新しいトランスフェクション技術の高度化により、ユーザーのトレーニングや既存のワークフローへの統合に課題が生じる可能性があります。

これらの市場促進要因・課題がトランスフェクション試薬・装置市場を形成し、業界の成長パターンや戦略的意思決定に影響を与えています。

目次

第1章 エグゼクティブサマリー

第2章 世界のトランスフェクション試薬・装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のトランスフェクション試薬・装置市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のトランスフェクション試薬・装置市場：製品別
  • 試薬
  • 装置
• 世界のトランスフェクション試薬・装置市場：手法別
  • 物理的方法
  • 生化学的方法
  • ウイルスによる方法
• 世界のトランスフェクション試薬・装置市場：用途別
  • タンパク質生産
  • 生物医学研究
  • 治療提供
• 世界のトランスフェクション試薬・装置市場：最終用途別
  • 学術・調査機関
  • 製薬・バイオテクノロジー企業
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のトランスフェクション試薬・装置市場：地域別
• 北米のトランスフェクション試薬・装置市場
• 欧州のトランスフェクション試薬・装置市場
• アジア太平洋のトランスフェクション試薬・装置市場
• その他地域のトランスフェクション試薬・装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のトランスフェクション試薬・装置市場の成長機会：製品別
  • 世界のトランスフェクション試薬・装置市場の成長機会：手法別
  • 世界のトランスフェクション試薬・装置市場の成長機会：用途別
  • 世界のトランスフェクション試薬・装置市場の成長機会：最終用途別
  • 世界のトランスフェクション試薬・装置市場の成長機会：地域別
• 世界のトランスフェクション試薬・装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のトランスフェクション試薬・装置市場の生産能力拡大
  • 世界のトランスフェクション試薬・装置市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and pharmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $2.1 billion by 2031 with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

• Lucintel forecasts that, within the product category, the reagent is expected to witness higher growth over the forecast period due to a huge number of launches by key players to broaden their reagents portfolio.
• Within the end use category, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.
• In terms of regions, North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is evolving with several notable trends:

• Nanoparticle-Based Reagents: These reagents are becoming popular due to their effectiveness in gene delivery with minimal cytotoxicity. Their superior stability and targeting capabilities lead to higher success rates in transfection.
• Transfection Automation: Automation technologies facilitate high-throughput screening, reducing manual intervention. Automated systems enhance reproducibility and efficiency, supporting extensive research and therapeutic applications.
• Advanced Electroporation Systems: New developments in electroporation technology improve the precision and efficiency of gene delivery, enhancing the intracellular delivery of nucleic acids for gene therapy and genetic research.
• Integration with Gene Editing Tools: The merging of transfection technologies with tools like CRISPR/Cas9 is gaining traction, increasing the efficiency and specificity of genetic modifications.
• Applications in Personalized Medicine: Transfection technologies are increasingly tailored to individual genetic backgrounds, enhancing their effectiveness in gene therapies and targeted treatments.

These trends are driving innovation and expanding the applications of transfection reagents and equipment, thereby improving research and therapeutic development prospects.

Recent Developments in the Transfection Reagent and Equipment Market

Key developments in the transfection reagent and equipment market include:

• Nanoparticle Innovations: Advanced nanoparticle-based transfection reagents are enhancing gene delivery efficiency while reducing cytotoxicity, making them suitable for diverse research and therapeutic applications.
• High-Throughput Systems: The introduction of high-throughput transfection systems is streamlining workflows and increasing productivity in genomic research by enabling simultaneous processing of multiple samples.
• Cost-Effective Solutions: The design of novel, affordable reagents and equipment is making advanced transfection technologies more accessible, especially in developing regions, thus enhancing global research and development.
• Electroporation Technologies: New electroporation systems offer improved control over gene delivery accuracy and efficiency, expanding applications in gene therapy and cellular research.
• Integration with Advanced Technologies: The latest transfection technologies are increasingly integrated with advanced tools like CRISPR/Cas9, facilitating precise genetic alterations and innovative therapeutic approaches.

These developments are propelling the field towards more efficient, accessible, and precise applications.

Strategic Growth Opportunities for Transfection Reagent and Equipment Market

Several strategic growth opportunities exist within the transfection reagent and equipment market:

• Gene Therapy: The growing use of transfection technologies in gene therapy presents significant growth opportunities, enhancing the delivery of therapeutic genes and improving treatment outcomes.
• Drug Discovery: Transfection technologies are becoming essential in drug discovery processes, enabling rapid studies of gene function and drug interactions, thus accelerating new drug development.
• Cancer Research: Enhanced methodologies for gene delivery are crucial for cancer research, improving the study of cancer-related genes and therapeutic targets.
• Regenerative Medicine: Transfection technologies are vital in developing new treatments within regenerative medicine, contributing to advancements in tissue engineering and stem cell research.
• Agricultural Biotechnology: There is significant potential for transfection technologies in agricultural biotechnology, aiding in the development of genetically modified crops for enhanced food safety and agricultural productivity.

These growth opportunities are expanding the application of transfection technologies across various sectors, driving market growth and innovation.

Transfection Reagent and Equipment Market Driver and Challenges

The various factors affecting the transfection reagent and equipment market include technological, economic, and regulatory. Below is an analysis of major drivers and challenges:

The factors responsible for driving the transfection reagent and equipment market include:

• Technological Advancements: Innovations like nanoparticles and automation improve gene delivery, driving market growth through enhanced efficiency and effectiveness.
• Increased Research Investments: Growing investments in biotechnology and genomic research are boosting demand for advanced transfection technologies, leading to market expansion.
• Rising Demand for Gene Therapies: The expanding applications of gene therapy create a heightened need for effective transfection technologies, catalyzing market growth.
• Personalized Medicine: The advancement of personalized medicine necessitates tailored transfection techniques, further driving demand for customized solutions.

Challenges in the transfection reagent and equipment market are:

• High Costs: The expense of sophisticated transfection reagents and equipment can deter use, particularly in smaller research facilities in developing regions.
• Complexity of Technologies: The sophistication of new transfection technologies can present challenges in user training and integration into existing workflows.

These drivers and challenges shape the transfection reagent and equipment market, influencing growth patterns and strategic decisions within the industry.

List of Transfection Reagent and Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transfection reagents and equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment market by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Analysis by Value from 2019 to 2031]:

• Reagents
• Equipment

Transfection Reagent and Equipment Market by Method [Analysis by Value from 2019 to 2031]:

• Physical Methods
• Biochemical Methods
• Viral Methods

Transfection Reagent and Equipment Market by Application [Analysis by Value from 2019 to 2031]:

• Protein Production
• Biomedical Research
• Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Academics & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Transfection Reagent and Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is rapidly evolving, driven by continuous technological advancements and expanding applications in research and therapeutics. Recent developments in key markets include:

• United States: The U.S. market is experiencing significant growth due to advancements in nanoparticle-based transfection reagents and electroporation equipment, improving gene delivery efficiency for research and therapeutic applications.
• China: Increased domestic production of affordable reagents and equipment is fostering growth in China, enhancing accessibility for local researchers and biotech firms.
• Germany: Ongoing development of high-throughput transfection systems and reagents in Germany is improving workflow efficiency in genomic research and pharmaceutical development.
• India: Investment in biotechnology research and development is driving growth in transfection technologies, with initiatives focused on creating affordable and scalable solutions.
• Japan: Japan is prioritizing the integration of microfluidics and gene editing tools in transfection systems, enhancing precision and efficiency in gene delivery for various applications.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Transfection Reagent and Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Transfection Reagent and Equipment Market by Product
  • 3.3.1: Reagents
  • 3.3.2: Equipment
• 3.4: Global Transfection Reagent and Equipment Market by Method
  • 3.4.1: Physical Methods
  • 3.4.2: Biochemical Methods
  • 3.4.3: Viral Methods
• 3.5: Global Transfection Reagent and Equipment Market by Application
  • 3.5.1: Protein Production
  • 3.5.2: Biomedical Research
  • 3.5.3: Therapeutic Delivery
• 3.6: Global Transfection Reagent and Equipment Market by End Use
  • 3.6.1: Academics & Research Institutes
  • 3.6.2: Pharmaceutical & Biotechnology Companies
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Transfection Reagent and Equipment Market by Region
• 4.2: North American Transfection Reagent and Equipment Market
  • 4.2.1: North American Market by Product: Reagents and Equipment
  • 4.2.2: North American Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.3: European Transfection Reagent and Equipment Market
  • 4.3.1: European Market by Product: Reagents and Equipment
  • 4.3.2: European Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.4: APAC Transfection Reagent and Equipment Market
  • 4.4.1: APAC Market by Product: Reagents and Equipment
  • 4.4.2: APAC Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.5: ROW Transfection Reagent and Equipment Market
  • 4.5.1: ROW Market by Product: Reagents and Equipment
  • 4.5.2: ROW Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
  • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
  • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
  • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
  • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
• 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PromoCell
• 7.2: OriGene Technologies
• 7.3: Thermos Fisher Scientific
• 7.4: Merck
• 7.5: Bio-Rad Laboratories
• 7.6: Lonza
• 7.7: Qiagen N.V.
• 7.8: Mirus Bio
• 7.9: Promega Corporation
• 7.10: F. Hoffmann-La Roche